Abstract
Introduction
The role in the development of schizophrenia of an extensive number of genetic and environmental factors has been examined, but a clarification of the pathogenic mechanisms is still needed (1, 2) .
Substance use has been suggested as a potential risk factor (3) . Cannabis, stimulants, cocaine and alcohol can cause transient psychosis (4) (5) (6) (7) (8) . Research suggests a pathophysiological explanation of the psychotic outcome of some of the substances could be increased striatal dopamine level (9) (10) (11) (12) (13) .
A similar neurobiological response is the leading theory of the psychotic symptoms in schizophrenia (14, 15) . Combined with a high prevalence of substance use among patients with schizophrenia, this has raised the hypothesis of whether they could be a cause of the disorder (16, 17) .
The hypothesis has been tested in several studies, with cannabis as the dominant focus. The majority of the papers suggests a causal correlation (3, (18) (19) (20) . In the most comprehensive review on the subject, performing meta-analysis the authors found a 40% higher risk of developing psychosis with people who had used cannabis. The authors estimated that if the association was truly causal, 14% of incident cases of psychosis could be prevented if cannabis was not used (3) . This is a cause of concern because of the prolonged increase in the incidence rate for cannabis use in Europe (21).
However, several limitations in the existing literature due to study-designs with high risk of selection bias and loss-to-follow up as well as difficulties in reducing the confounding effect of a transient intoxication of a substance has retained the uncertainty of the direction of causation (3, 22, 23) .
We aimed to investigate whether substance abuse can increase the risk of developing schizophrenia, addressing some of the limitations of prior studies, examining the hypothesis with the largest number of participants and types of substances to date.
Methods
The study population consisted of all born in Denmark between January 1, 1955 and December 31, 1999, and was extracted from The Danish Civil Registration System (CRS) which has collected information on the whole Danish population since 1968 (27) . Information was extracted from The Danish Psychiatric Central Research Register (PCR) (since 1969), the Danish National Patient Register (NPa), the Danish National Prescription Registry (NPre), the National Alcohol Treatment Register (NAB) and the National Substance Abuse Register (SIB) (24) (25) (26) (27) (28) (29) . A personal identification number is used in all the national registers, enabling an accurate linkage between the registers.
Substance abuse was defined as reported in table 1, and schizophrenia was defined as ICD-8: 295.x, except 295.7 and ICD-10: F20.x. The date of onset of substance abuse and schizophrenia was defined as the date of first contact leading to the diagnoses. Psychotic symptoms caused by substances (ICD-10: 1x.5, 1x.7 and 1x.8) was not included in the definition of substance abuse, as these diagnoses represent a group with a higher vulnerability of developing psychotic disorder. All individuals diagnosed with schizophrenia less than a year after a registration of abuse were classified as nonabuser. 
Statistical analyses
The population was followed from birth until diagnosis of schizophrenia, emigration from Denmark, death, or July 1, 2013, whichever came first.
HR (assessments of relative risk) were estimated performing Cox regression analyses using StataMP statistical software, version 13, with substance use disorders as time varying covariates. The p-value and 95% CI were based on likelihood ratio test. We primarily adjusted for other types of substance abuse, to determine the effect of a concurrent substance abuse on the associations. Secondary analyses were additionally adjusted for calendar year (continuous, time-varying variable), gender, urbanicity (born in cities with > 100,000 or <100,000 residents), other non-schizophrenia, non-substance-abuse We performed additional analysis for interaction of gender and sensitivity analysis on the population born after 1980 as information on outpatients and emergency room contacts were added in 1995 and by that completing the register.
The identities of the cohort members were blinded to the investigators. The study was approved by the Danish Data Protection Agency.
Results
The Kaplan Meier curves illustrates the proportion of incident diagnosis of schizophrenia (figure 1). Figure 2 illustrates the risk of being diagnosed with schizophrenia was strongest within a year after diagnosed with substance abuse. The risk decreased in the subsequent years, but remained significant even after 10-15 years. 
Discussion
We found, an association between almost any kind of substance abuse and schizophrenia, with abuse of cannabis and alcohol presenting the highest risks. After all adjustments were made the HR were reduced however still significant for almost all types of substances. The risk of developing schizophrenia was significantly increased even 10-15 years subsequent a substance abuse. We found in general stronger associations compared with estimates reported in other studies (3, 5, 20) . However, this could be explained by our investigation of substance abuse in comparison to previous studies examining the association with substance use on a broader scale, as previous papers on cannabis use have found statistical evidence in favour of a dose-response relationship (3). One other study investigated substance abuse as a risk factor, and found in general higher associations compared with the present study (19) . However, a lack of adjustment for other types of substances could overestimated these results. We found, that the attenuation of the HR between the unadjusted and fully adjusted results was largely caused by the effect of a poly-drug abuse, which brings new information to the area (data not reported). Conversely, the adjustment could also cause an overadjustment, illustrated by the finding of a negative association with cocaine, as the crude results highly indicate the reverse association. The lower HR found in the sensitivity analysis of the 1980-population could be explained by the markedly lower number of cases (5.857 cases). Conversely, the result could be closer to the true measure of association, as it is based on a more complete psychiatric information.
The strengths of the study are the longitudinal, prospective design based on the nationwide Danish registers, ensuring a large study population and a high number of cases with a minimum of loss-tofollow up and recall bias effects (24, 28) . Extracting information from several registers increased the number of registered abusers, however, an underestimation of the diagnosis of substance abuse must be anticipated. The sparse data on the psychological development from birth from the registers on this area is a study limitation as well.
The rule of classifying any diagnosed with schizophrenia less than a year after a substance abuse as non-abuser is conservative. However, the rule addressed the effects of the disorders developing in an individual length of time prior to the registration in the registers as well as detection bias caused by a hospital contact for schizophrenia possibly entailing a subsequent risk of being diagnosed with a substance abuse (figure 2). Other confounders could have affected the results as well (34, 35) .
In conclusion, the consumption of substances is an extensive problem throughout the world and a current debate on legalizing cannabis in many countries has made uncovering the risk of abusing substances an important area of investigation (21,36). We found robust associations between a wide variety of substance abuse and an increased risk of developing schizophrenia. We are not aware of any other study focusing on the effect of such a wide variety of substance abuse and the interaction between the abuses as our study.
